SCHEMBL9360977

SCHEMBL9360977

O=S(=O)(O)c1ccccc1S(=O)(=O)Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.44
ALDH1A1 P00352 2/20 0.44
HSD17B10 Q99714 1/20 0.44
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MYC P01106 1/20 0.44
TTR P02766 2/20 0.42
SNCA P37840 2/20 0.39
CHAT P28329 1/20 0.39
FABP4 P15090 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
MAPK14 Q16539 1/20 0.38
NR4A1 P22736 1/20 0.37
PGAM1 P18669 1/20 0.36
MPL P40238 2/20 0.36
CYP1A2 P05177 1/20 0.36
GAA P10253 2/20 0.36
TRPV4 Q9HBA0 1/20 0.35
CA1 P00915 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL150335 0.87 TSHR (0.55) TDP1ALDH1A1TSHRSMN1; SMN2MYC
SCHEMBL250199 0.87 ALDH1A1 (0.55) TDP1ALDH1A1HSD17B10TSHRSMN1; SMN2
SCHEMBL29664068 0.87 TSHR (0.55) TDP1ALDH1A1TSHRSMN1; SMN2MYC
SCHEMBL8607533 0.84 TSHR (0.52) TDP1ALDH1A1TSHRSMN1; SMN2MYC
SCHEMBL6678754 0.84 TSHR (0.52) TDP1ALDH1A1TSHRSMN1; SMN2MYC
Potassium SCHEMBL999033 0.84 TSHR (0.52) TDP1ALDH1A1TSHRSMN1; SMN2MYC
SCHEMBL6552111 0.84 TSHR (0.52) TDP1ALDH1A1TSHRSMN1; SMN2MYC
SCHEMBL2291963 0.84 TSHR (0.52) TDP1ALDH1A1TSHRSMN1; SMN2MYC
SCHEMBL2972939 0.84 TSHR (0.52) TDP1ALDH1A1TSHRSMN1; SMN2MYC
Hydrochloric Acid SCHEMBL627715 0.84 TSHR (0.52) TDP1ALDH1A1TSHRSMN1; SMN2MYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100361992-C Sulfonamide substituted xanthine derivatives for use as PEPCK inhibitors HOFFMANN LA ROCHE (CH) 2008-01-16 CN disclosed
CN-1751044-A Sulfonamide substituted xanthine derivatives for use as PEPCK inhibitors HOFFMANN LA ROCHE (CH) 2006-03-22 CN disclosed
EP-0214853-B1 Viscoelastic collagen solution for ophthalmic use and method of preparation MINNESOTA MINING & MFG (US) 1994-11-30 EP disclosed
US-4883864-A COUPLED AND FREE AMINE GROUPS CAPPED WITH UREA OR AMIDE GROUPS, EYE SURGERY MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-11-28 US disclosed
US-4851513-A Viscoelastic collagen solution for opthalmic use and method of preparation MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-07-25 US disclosed
US-4835312-A Production process of N-substituted amide compounds MITSUI CHEMICALS, INCORPORATED (JP) 1989-05-30 US disclosed
US-4713446-A COLLAGEN COUPLED TO CARBONYL OR SULFONYL GROUPS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1987-12-15 US disclosed
EP-0214853-A2 Viscoelastic collagen solution for ophthalmic use and method of preparation MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1987-03-18 EP disclosed